Veterinary Medicines

Oculoheel Augentropfen ad us. vet.

Authorised
  • COCHLEARIA OFFICINALIS D5
  • ECHINACEA D5
  • EUPHRASIA D5
  • PILOCARPUS D5
Download as PDF

Product identification

Medicine name:
Oculoheel Augentropfen ad us. vet.
Active substance:
  • COCHLEARIA OFFICINALIS D5
  • ECHINACEA D5
  • EUPHRASIA D5
  • PILOCARPUS D5
Target species:
  • Cattle
  • Dog
  • Goat
  • Sheep
  • Horse
  • Cat
  • Pig
  • Small pets
Route of administration:
  • Ocular use

Product details

Active substance and strength:
  • COCHLEARIA OFFICINALIS D5
    110.70
    milligram(s)
    /
    0.45
    millilitre(s)
  • ECHINACEA D5
    110.70
    milligram(s)
    /
    0.45
    millilitre(s)
  • EUPHRASIA D5
    110.70
    milligram(s)
    /
    0.45
    millilitre(s)
  • PILOCARPUS D5
    110.70
    milligram(s)
    /
    0.45
    millilitre(s)
Pharmaceutical form:
  • Eye drops, solution
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Homeopathic Registration
Marketing authorisation holder:
  • Biologische Heilmittel Heel GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biologische Heilmittel Heel GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 401159.00.00
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 13/01/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 13/01/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."